Drug Approval Package
-
Xyzal (levocetirizine dihydrochloride) 5mg Tablets
Company: UCB, Inc.
NDA: 022064
Approval Date: 5/25/2007
- Approval Letter(s) (PDF)
- Printed Labeling (PDF)
- Summary Review (PDF)
- Medical Review(s)
- Chemistry Review(s) (PDF)
- Pharmacology Review(s) (PDF)
- Statistical Review(s) (PDF)
- Clinical Pharmacology Biopharmaceutics Review(s) (PDF)
- Proprietary Name Review(s) (PDF)
- Administrative Document(s) and Correspondence
Date created: October 15, 2008
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-